When DR5‐treated tumor cells and jurkat co‐culture reporter assays were evaluated in the presence of ROCK1 inhibitors, luciferase activity was significantly enhanced in lieu with loss of surface PD‐L1 (Fig 4I and J and Appendix Fig S8D). The gene discussed is CD274; the disease is neoplasm.